DJIA 17,719.00 33.27 0.19%
NASDAQ 4,701.87 26.16 0.56%
S&P 500 2,052.75 4.03 0.20%
market minute promo

Seattle Genetics (NASDAQ: SGEN)

36.60 0.36 (0.99%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SGEN $36.60 0.99%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $36.14
Previous Close $36.24
Daily Range $35.78 - $37.05
52-Week Range $30.80 - $55.99
Market Cap $4.5B
P/E Ratio -69.69
Dividend (Yield) $0.00 (0.0%)
Volume 669,165
Average Daily Volume 1,316,347
Current FY EPS -$0.68

Sector

Healthcare

Industry

Drugs

Seattle Genetics (SGEN) Description

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Website: http://www.seattlegenetics.com/

News & Commentary

3 Biotech Stocks to Watch in November

Biotech can be a tough sector for many investors. Here, our analysts share their three favorite picks as we go into November.

Why the Earnings Streak Will Continue for Seattle Genetics (SGEN) - Tale of the Tape

Friday's ETF Movers: GDXJ, BBH

5 Stocks With Big Insider Buying

Seattle Genetics (SGEN) Shows Signs Of Being Water-Logged And Getting Wetter

5 Health Care Stocks Hurting From The Affordable Care Act

Seattle Genetics Gains on Narrower-than-Expected Q3 Loss - Analyst Blog

Seattle Genetics' (SGEN) CEO Clay Siegall on Q3 2014 Results - Earnings Call Transcript

Analysts' Actions: Aegerion, Atmel, Avon, Seattle Genetics, More

Seattle Genetics, Inc. Posts Record Adcetris Sales

A solid quarter for the biotech allowed it to raise guidance for the year.

See More SGEN News...

SGEN's Top Competitors

SGEN $36.60 (0.99%)
Current stock: SGEN
AMGN $162.68 (0.02%)
Current stock: AMGN
GILD $100.59 (-1.71%)
Current stock: GILD
BIIB $299.10 (-1.49%)
Current stock: BIIB